In this market, I managed to find two interesting companies.
- Integral Systems (ISYS) builds satellite ground systems and equipment for command and control, integration and test, data processing and simulation. The stock is near its 52 week high despite the bad market. The company has a forward PE of 19, and a 5 year estimated growth rate of 22.5% for a PEG of 0.85 which is very good, having a PEG of less than 1.
- OSI Pharmaceuticals (OSIP) is a biotech company that discovers, develops, and commercializes molecular targeted therapies for oncology, diabetes and obesity. Its flagship product is Tarceva, used to treat advanced non-small cell lung cancer, as well as other forms of cancer such as pancreatic cancer. OSIP has a forward PE of 18.4, and a 5 year estimated growth estimate of 34%. It has a PEG of around 0.5, which is very low. The stock is near its 52 week high despite the bad market.